Keyphrases
High-risk Human Papillomavirus (HR-HPV)
100%
Laryngeal Squamous Cell Carcinoma
100%
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
100%
P21 Expression
100%
CDKN1A
100%
Tumor
66%
Overall Survival
22%
Oropharynx
22%
P16-positive
22%
E7 mRNA
22%
Virus
11%
Quantitative PCR
11%
In Situ Hybridization
11%
Strong Correlation
11%
Positive Groups
11%
Intraoperative Radiation Therapy
11%
Surrogate Marker
11%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
11%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
11%
Primary Surgery
11%
Transcriptionally Active
11%
Clinicopathological Significance
11%
DNA Hybridization
11%
Papillomavirus Infections
11%
Radiation-based Method
11%
Keratinizing
11%
Definitive Radiation
11%
Non-keratinizing
11%
P16 Immunohistochemistry
11%
Non-oropharyngeal
11%
Unexpected Results
11%
High-risk Human Papillomavirus DNA
11%
Medicine and Dentistry
Squamous Cell Carcinoma
100%
Wart Virus
100%
P21
100%
P16
100%
Larynx
100%
Neoplasm
66%
Overall Survival
22%
Oropharynx
22%
Messenger RNA
22%
In Situ Hybridization
22%
Biological Marker
11%
Immunohistochemistry
11%
Prevalence
11%
Disease Marker
11%
Oropharynx Squamous Cell Carcinoma
11%
Papillomavirus Infection
11%
Head and Neck Carcinoma
11%
Larynx Squamous Cell Carcinoma
11%
Reverse Transcription Polymerase Chain Reaction
11%
Virus
11%
Pharmacology, Toxicology and Pharmaceutical Science
Squamous Cell Carcinoma
100%
Human Papillomavirus
100%
Neoplasm
66%
Overall Survival
22%
Messenger RNA
22%
Biological Marker
11%
Prevalence
11%
RNA Directed DNA Polymerase
11%
Papillomavirus Infection
11%
Disease Marker
11%
Oropharynx Squamous Cell Carcinoma
11%
Larynx Squamous Cell Carcinoma
11%
Head and Neck Carcinoma
11%
Immunology and Microbiology
Wart Virus
100%
Squamous Cell
100%
Overall Survival
20%
Oropharynx
20%
In Situ Hybridization
20%
Prevalence
10%
Neck
10%
Reverse Transcription Polymerase Chain Reaction
10%
Virus
10%